BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31878336)

  • 1. Dampened Slow Oscillation Connectivity Anticipates Amyloid Deposition in the PS2APP Mouse Model of Alzheimer's Disease.
    Leparulo A; Mahmud M; Scremin E; Pozzan T; Vassanelli S; Fasolato C
    Cells; 2019 Dec; 9(1):. PubMed ID: 31878336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early hippocampal hyperexcitability in PS2APP mice: role of mutant PS2 and APP.
    Fontana R; Agostini M; Murana E; Mahmud M; Scremin E; Rubega M; Sparacino G; Vassanelli S; Fasolato C
    Neurobiol Aging; 2017 Feb; 50():64-76. PubMed ID: 27889678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceleration of amyloidogenesis and memory impairment by estrogen deficiency through NF-κB dependent beta-secretase activation in presenilin 2 mutant mice.
    Hwang CJ; Park MH; Choi MK; Choi JS; Oh KW; Hwang DY; Han SB; Hong JT
    Brain Behav Immun; 2016 Mar; 53():113-122. PubMed ID: 26593275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated Aging Characterizes the Early Stage of Alzheimer's Disease.
    Leparulo A; Bisio M; Redolfi N; Pozzan T; Vassanelli S; Fasolato C
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presenilin-2 mutation causes early amyloid accumulation and memory impairment in a transgenic mouse model of Alzheimer's disease.
    Toda T; Noda Y; Ito G; Maeda M; Shimizu T
    J Biomed Biotechnol; 2011; 2011():617974. PubMed ID: 21234330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disturbed cross talk between insulin-like growth factor I and AMP-activated protein kinase as a possible cause of vascular dysfunction in the amyloid precursor protein/presenilin 2 mouse model of Alzheimer's disease.
    Lopez-Lopez C; Dietrich MO; Metzger F; Loetscher H; Torres-Aleman I
    J Neurosci; 2007 Jan; 27(4):824-31. PubMed ID: 17251422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss.
    Takeuchi A; Irizarry MC; Duff K; Saido TC; Hsiao Ashe K; Hasegawa M; Mann DM; Hyman BT; Iwatsubo T
    Am J Pathol; 2000 Jul; 157(1):331-9. PubMed ID: 10880403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Relationship Between Cognitive Impairment, Glycometabolism, and Nicotinic Acetylcholine Receptor Deficits in a Mouse Model of Alzheimer's Disease.
    Matsuura Y; Ueda M; Higaki Y; Sano K; Saji H; Enomoto S
    Mol Imaging Biol; 2019 Jun; 21(3):519-528. PubMed ID: 30047036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice.
    Citron M; Westaway D; Xia W; Carlson G; Diehl T; Levesque G; Johnson-Wood K; Lee M; Seubert P; Davis A; Kholodenko D; Motter R; Sherrington R; Perry B; Yao H; Strome R; Lieberburg I; Rommens J; Kim S; Schenk D; Fraser P; St George Hyslop P; Selkoe DJ
    Nat Med; 1997 Jan; 3(1):67-72. PubMed ID: 8986743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presenilin 2 mutation accelerates the onset of impairment in trace eyeblink conditioning in a mouse model of Alzheimer's disease overexpressing human mutant amyloid precursor protein.
    Kishimoto Y; Kirino Y
    Neurosci Lett; 2013 Mar; 538():15-9. PubMed ID: 23370287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtle behavioral changes and increased prefrontal-hippocampal network synchronicity in APP
    Latif-Hernandez A; Shah D; Craessaerts K; Saido T; Saito T; De Strooper B; Van der Linden A; D'Hooge R
    Behav Brain Res; 2019 May; 364():431-441. PubMed ID: 29158112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions.
    van Groen T; Liu L; Ikonen S; Kadish I
    Neuroscience; 2003; 119(4):1185-97. PubMed ID: 12831872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice.
    Dewachter I; Reversé D; Caluwaerts N; Ris L; Kuipéri C; Van den Haute C; Spittaels K; Umans L; Serneels L; Thiry E; Moechars D; Mercken M; Godaux E; Van Leuven F
    J Neurosci; 2002 May; 22(9):3445-53. PubMed ID: 11978821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice.
    Wang J; Tanila H; Puoliväli J; Kadish I; van Groen T
    Neurobiol Dis; 2003 Dec; 14(3):318-27. PubMed ID: 14678749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
    Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
    J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice.
    Wirths O; Multhaup G; Czech C; Blanchard V; Moussaoui S; Tremp G; Pradier L; Beyreuther K; Bayer TA
    Neurosci Lett; 2001 Jun; 306(1-2):116-20. PubMed ID: 11403971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
    Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
    Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease.
    Zhang C; McNeil E; Dressler L; Siman R
    Exp Neurol; 2007 Mar; 204(1):77-87. PubMed ID: 17070803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.